As seen in Fig. 4, dosing with [177Lu]Lu-PSMA-1-DOTA was able to eliminate tumor growth for 24 days similarly to [177Lu]Lu-PSMA-617, which was used as a positive control for RLT. Here, FOLH1 is linked to neoplasm.